{"audit_author": [{"name": "Banner, D.W.", "pdbx_ordinal": 1}, {"name": "Benz, J.", "pdbx_ordinal": 2}, {"name": "Schlatter, D.", "pdbx_ordinal": 3}, {"name": "Anselm, L.", "pdbx_ordinal": 4}, {"name": "Haap, W.", "pdbx_ordinal": 5}], "cell": {"angle_alpha": 90.0, "angle_beta": 90.0, "angle_gamma": 90.0, "length_a": 105.98, "length_b": 105.98, "length_c": 50.44, "zpdb": 8}, "citation": [{"country": "UK", "id": "primary", "journal_abbrev": "Bioorg.Med.Chem.", "journal_id_astm": "BMECEP", "journal_id_csd": "1200", "journal_id_issn": "0968-0896", "journal_volume": "20", "page_first": "5313", "pdbx_database_id_doi": "10.1016/J.BMCL.2010.06.126", "pdbx_database_id_pub_med": 20650636, "rcsb_authors": ["Anselm, L.", "Banner, D.W.", "Benz, J.", "Groebke Zbinden, K.", "Himber, J.", "Hilpert, H.", "Huber, W.", "Kuhn, B.", "Mary, J.L.", "Otteneder, M.B.", "Panday, N.", "Ricklin, F.", "Stahl, M.", "Thomi, S.", "Haap, W."], "rcsb_is_primary": "Y", "rcsb_journal_abbrev": "Bioorg Med Chem", "title": "Discovery of a Factor Xa Inhibitor (3R,4R)-1-(2,2-Difluoro-Ethyl)-Pyrrolidine-3,4-Dicarboxylic Acid 3-[(5-Chloro-Pyridin-2-Yl)-Amide] 4-{[2-Fluoro-4-(2-Oxo-2H-Pyridin-1-Yl)-Phenyl]-Amide} as a Clinical Candidate.", "year": 2010}], "diffrn": [{"ambient_temp": 100.0, "crystal_id": "1", "id": "1"}], "diffrn_detector": [{"detector": "CCD", "diffrn_id": "1", "pdbx_collection_date": "2004-05-04T00:00:00+0000", "type": "MARRESEARCH"}], "diffrn_radiation": [{"diffrn_id": "1", "pdbx_diffrn_protocol": "SINGLE WAVELENGTH", "pdbx_monochromatic_or_laue_ml": "M", "pdbx_scattering_type": "x-ray", "wavelength_id": "1"}], "diffrn_source": [{"diffrn_id": "1", "pdbx_synchrotron_beamline": "X06SA", "pdbx_synchrotron_site": "SLS", "pdbx_wavelength": "0.9793", "source": "SYNCHROTRON", "type": "SLS BEAMLINE X06SA"}], "entry": {"id": "2XC5"}, "exptl": [{"crystals_number": 1, "method": "X-RAY DIFFRACTION"}], "exptl_crystal": [{"density_matthews": 2.31, "density_percent_sol": 46.7, "description": "LOW COMPLETENESS DUE TO ICE RING EXCLUSION", "id": "1"}], "exptl_crystal_grow": [{"crystal_id": "1", "p_h": 6.5, "pdbx_details": "PH 6.5"}], "pdbx_audit_revision_details": [{"data_content_type": "Structure model", "ordinal": 1, "provider": "repository", "revision_ordinal": 1, "type": "Initial release"}], "pdbx_audit_revision_group": [{"data_content_type": "Structure model", "group": "Version format compliance", "ordinal": 1, "revision_ordinal": 2}, {"data_content_type": "Structure model", "group": "Version format compliance", "ordinal": 2, "revision_ordinal": 3}], "pdbx_audit_revision_history": [{"data_content_type": "Structure model", "major_revision": 1, "minor_revision": 0, "ordinal": 1, "revision_date": "2010-08-04T00:00:00+0000"}, {"data_content_type": "Structure model", "major_revision": 1, "minor_revision": 1, "ordinal": 2, "revision_date": "2011-05-08T00:00:00+0000"}, {"data_content_type": "Structure model", "major_revision": 1, "minor_revision": 2, "ordinal": 3, "revision_date": "2011-07-13T00:00:00+0000"}], "pdbx_database_related": [{"content_type": "unspecified", "db_id": "1WU1", "db_name": "PDB", "details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL- 2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL) PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"content_type": "unspecified", "db_id": "2J34", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "2BQ7", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"content_type": "unspecified", "db_id": "2W3K", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}, {"content_type": "unspecified", "db_id": "2VWO", "db_name": "PDB", "details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"content_type": "unspecified", "db_id": "1XKA", "db_name": "PDB", "details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"content_type": "unspecified", "db_id": "1NFW", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"content_type": "unspecified", "db_id": "2GD4", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA- PENTASACCHARIDE COMPLEX"}, {"content_type": "unspecified", "db_id": "2VVV", "db_name": "PDB", "details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"content_type": "unspecified", "db_id": "1MSX", "db_name": "PDB", "details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO- 13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3, 5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"content_type": "unspecified", "db_id": "1LPG", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"content_type": "unspecified", "db_id": "2VVU", "db_name": "PDB", "details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"content_type": "unspecified", "db_id": "1P0S", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"content_type": "unspecified", "db_id": "2G00", "db_name": "PDB", "details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'- ((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3- (TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C] PYRIDIN-1- YL)BENZAMIDE"}, {"content_type": "unspecified", "db_id": "1MQ6", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2- PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5- DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"content_type": "unspecified", "db_id": "1XKB", "db_name": "PDB", "details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"content_type": "unspecified", "db_id": "1IQE", "db_name": "PDB", "details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"content_type": "unspecified", "db_id": "1G2M", "db_name": "PDB", "details": "FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "2VH0", "db_name": "PDB", "details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"content_type": "unspecified", "db_id": "1NFY", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"content_type": "unspecified", "db_id": "2UWL", "db_name": "PDB", "details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"content_type": "unspecified", "db_id": "2BOK", "db_name": "PDB", "details": "FACTOR XA - CATION"}, {"content_type": "unspecified", "db_id": "1HCG", "db_name": "PDB", "details": "BLOOD COAGULATION FACTOR XA"}, {"content_type": "unspecified", "db_id": "1LPZ", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"content_type": "unspecified", "db_id": "2W3I", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}, {"content_type": "unspecified", "db_id": "1Z6E", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"content_type": "unspecified", "db_id": "2JKH", "db_name": "PDB", "details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "2UWP", "db_name": "PDB", "details": "FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "1G2L", "db_name": "PDB", "details": "FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "1NFU", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"content_type": "unspecified", "db_id": "2BQ6", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"content_type": "unspecified", "db_id": "1FAX", "db_name": "PDB", "details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "1IQF", "db_name": "PDB", "details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"content_type": "unspecified", "db_id": "1NL8", "db_name": "PDB", "details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/ FACTORXA COMPLEX"}, {"content_type": "unspecified", "db_id": "1IQG", "db_name": "PDB", "details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"content_type": "unspecified", "db_id": "1IQH", "db_name": "PDB", "details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"content_type": "unspecified", "db_id": "1LQD", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"content_type": "unspecified", "db_id": "2UWO", "db_name": "PDB", "details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"content_type": "unspecified", "db_id": "1C5M", "db_name": "PDB", "details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"content_type": "unspecified", "db_id": "1IOE", "db_name": "PDB", "details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"content_type": "unspecified", "db_id": "1F0S", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"content_type": "unspecified", "db_id": "1F0R", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"content_type": "unspecified", "db_id": "1MQ5", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4- CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"content_type": "unspecified", "db_id": "2BMG", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"content_type": "unspecified", "db_id": "1IQN", "db_name": "PDB", "details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"content_type": "unspecified", "db_id": "2BQW", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"content_type": "unspecified", "db_id": "1IQM", "db_name": "PDB", "details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"content_type": "unspecified", "db_id": "1EZQ", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"content_type": "unspecified", "db_id": "2VWL", "db_name": "PDB", "details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"content_type": "unspecified", "db_id": "2VH6", "db_name": "PDB", "details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"content_type": "unspecified", "db_id": "1FJS", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA"}, {"content_type": "unspecified", "db_id": "1LPK", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"content_type": "unspecified", "db_id": "2J4I", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "1NFX", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"content_type": "unspecified", "db_id": "2VWN", "db_name": "PDB", "details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"content_type": "unspecified", "db_id": "2J94", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "1IQJ", "db_name": "PDB", "details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"content_type": "unspecified", "db_id": "2J95", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "2CJI", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "2BOH", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"content_type": "unspecified", "db_id": "2J38", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "2W26", "db_name": "PDB", "details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"content_type": "unspecified", "db_id": "2VVC", "db_name": "PDB", "details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"content_type": "unspecified", "db_id": "1IQI", "db_name": "PDB", "details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"content_type": "unspecified", "db_id": "2VWM", "db_name": "PDB", "details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"content_type": "unspecified", "db_id": "1KYE", "db_name": "PDB", "details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)- 3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"content_type": "unspecified", "db_id": "1IQK", "db_name": "PDB", "details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"content_type": "unspecified", "db_id": "2WYJ", "db_name": "PDB", "details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"content_type": "unspecified", "db_id": "1V3X", "db_name": "PDB", "details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6, 7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2- CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"content_type": "unspecified", "db_id": "2FZZ", "db_name": "PDB", "details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2- BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL) METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"content_type": "unspecified", "db_id": "2J2U", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "1KSN", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"content_type": "unspecified", "db_id": "1IQL", "db_name": "PDB", "details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"content_type": "unspecified", "db_id": "2WYG", "db_name": "PDB", "details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"content_type": "unspecified", "db_id": "2XBX", "db_name": "PDB", "details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"content_type": "unspecified", "db_id": "2XBY", "db_name": "PDB", "details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"content_type": "unspecified", "db_id": "2XBV", "db_name": "PDB", "details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"content_type": "unspecified", "db_id": "2XC0", "db_name": "PDB", "details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"content_type": "unspecified", "db_id": "2XC4", "db_name": "PDB", "details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"content_type": "unspecified", "db_id": "2XBW", "db_name": "PDB", "details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}], "pdbx_database_status": {"deposit_site": "PDBE", "pdb_format_compatible": "Y", "process_site": "PDBE", "recvd_initial_deposition_date": "2010-04-16T00:00:00+0000", "status_code": "REL"}, "pdbx_vrpt_summary": {"babinet_b": 156.25, "babinet_k": 0.283, "dcc_r": 0.19, "eds_r": 0.19, "fo_fc_correlation": 0.962, "pdb_r": 0.19, "wilson_baniso": "[27.672,27.672,28.552,0.000,0.000,0.000]", "wilson_bestimate": 27.96, "absolute_percentile_dccrfree": 58.0, "absolute_percentile_clashscore": 78.9, "absolute_percentile_percent_rsrzoutliers": 8.3, "absolute_percentile_percent_ramachandran_outliers": 34.0, "absolute_percentile_percent_rotamer_outliers": 90.8, "acentric_outliers": 0, "angles_rmsz": 0.65, "attempted_validation_steps": "molprobity,validation-pack,xtriage,eds,mogul,buster-report,percentiles,writexml", "bonds_rmsz": 0.58, "bulk_solvent_b": 43.248, "bulk_solvent_k": 0.287, "ccp4version": "7.0.044 (Gargrove)", "centric_outliers": 0.0, "clashscore": 2.78, "data_anisotropy": 0.031, "data_completeness": 82.56, "high_resol_relative_percentile_dccrfree": 1.7, "high_resol_relative_percentile_clashscore": 1.7, "high_resol_relative_percentile_percent_rsrzoutliers": 1.7, "high_resol_relative_percentile_percent_ramachandran_outliers": 1.7, "high_resol_relative_percentile_percent_rotamer_outliers": 1.7, "ligands_for_buster_report": "yes", "low_resol_relative_percentile_dccrfree": 1.7, "low_resol_relative_percentile_clashscore": 1.7, "low_resol_relative_percentile_percent_rsrzoutliers": 1.7, "low_resol_relative_percentile_percent_ramachandran_outliers": 1.7, "low_resol_relative_percentile_percent_rotamer_outliers": 1.7, "num_hreduce": 2115.0, "num_pdbids_absolute_percentile_dccrfree": 130704, "num_pdbids_absolute_percentile_clashscore": 141614, "num_pdbids_absolute_percentile_percent_rsrzoutliers": 127900, "num_pdbids_absolute_percentile_percent_ramachandran_outliers": 138981, "num_pdbids_absolute_percentile_percent_rotamer_outliers": 138945, "num_pdbids_relative_percentile_dccrfree": 4298, "num_pdbids_relative_percentile_clashscore": 4695, "num_pdbids_relative_percentile_percent_rsrzoutliers": 4222, "num_pdbids_relative_percentile_percent_ramachandran_outliers": 4610, "num_pdbids_relative_percentile_percent_rotamer_outliers": 4610, "num_angles_rmsz": 2982, "num_bonds_rmsz": 2212, "num_free_reflections": 1356, "num_miller_indices": 26539, "percent_rsrzoutliers": 9.29, "percent_free_reflections": 5.11, "percent_ramachandran_outliers": 0.36, "percent_rotamer_outliers": 0.43, "percentilebins": ["all", "1.7", "xray"], "protein_dnarnaentities": "1,2", "refmac_version": "5.8.0158", "relative_percentile_dccrfree": 31.2, "relative_percentile_clashscore": 73.6, "relative_percentile_percent_rsrzoutliers": 9.4, "relative_percentile_percent_ramachandran_outliers": 18.0, "relative_percentile_percent_rotamer_outliers": 86.8, "report_creation_date": "May 15, 2020 -- 01:23 pm BST", "restypes_notchecked_for_bond_angle_geometry": ["NA", "CA", "OYJ"], "trans_nsc": "The largest off-origin peak in the Patterson function is 5.48% of the height of the origin peak. No significant pseudotranslation is detected.", "twin_l": 0.471, "twin_l2": 0.301, "xtriage_input_columns": "F_meas_au,F_meas_sigma_au", "bfactor_type": "FULL", "dccrfree": 0.23, "dccrefinement_program": "REFMAC", "edsresolution": 1.7, "edsresolution_low": 19.22, "iover_sigma": "2.02(1.70A)", "pdbrfree": 0.23, "pdbdeposition_date": "2010-04-16T00:00:00+0000", "pdbresolution": 1.7, "pdbresolution_low": 74.94, "pdbrevision_date": "2011-07-13T00:00:00+0000", "pdbrevision_number": 3.0}, "rcsb_accession_info": {"deposit_date": "2010-04-16T00:00:00+0000", "has_released_experimental_data": "N", "initial_release_date": "2010-08-04T00:00:00+0000", "major_revision": 1, "minor_revision": 2, "revision_date": "2011-07-13T00:00:00+0000", "status_code": "REL"}, "rcsb_entry_container_identifiers": {"assembly_ids": ["1"], "entity_ids": ["1", "2", "3", "4", "5", "6"], "entry_id": "2XC5", "model_ids": [1], "non_polymer_entity_ids": ["3", "4", "5"], "polymer_entity_ids": ["1", "2"], "rcsb_id": "2XC5", "pubmed_id": 20650636}, "rcsb_entry_info": {"assembly_count": 1, "branched_entity_count": 0, "cis_peptide_count": 0, "deposited_atom_count": 2384, "deposited_hydrogen_atom_count": 0, "deposited_model_count": 1, "deposited_modeled_polymer_monomer_count": 280, "deposited_nonpolymer_entity_instance_count": 3, "deposited_polymer_entity_instance_count": 2, "deposited_polymer_monomer_count": 296, "deposited_solvent_atom_count": 175, "deposited_unmodeled_polymer_monomer_count": 16, "diffrn_radiation_wavelength_maximum": 0.9793, "diffrn_radiation_wavelength_minimum": 0.9793, "disulfide_bond_count": 8, "entity_count": 6, "experimental_method": "X-ray", "experimental_method_count": 1, "inter_mol_covalent_bond_count": 0, "inter_mol_metalic_bond_count": 12, "molecular_weight": 33.88, "na_polymer_entity_types": "Other", "nonpolymer_bound_components": ["CA", "NA"], "nonpolymer_entity_count": 3, "nonpolymer_molecular_weight_maximum": 0.55, "nonpolymer_molecular_weight_minimum": 0.02, "polymer_composition": "heteromeric protein", "polymer_entity_count": 2, "polymer_entity_count_dna": 0, "polymer_entity_count_rna": 0, "polymer_entity_count_nucleic_acid": 0, "polymer_entity_count_nucleic_acid_hybrid": 0, "polymer_entity_count_protein": 2, "polymer_entity_taxonomy_count": 2, "polymer_molecular_weight_maximum": 27.2, "polymer_molecular_weight_minimum": 6.06, "polymer_monomer_count_maximum": 241, "polymer_monomer_count_minimum": 55, "resolution_combined": [1.7], "selected_polymer_entity_types": "Protein (only)", "software_programs_combined": ["MOLREP", "REFMAC", "XDS"], "solvent_entity_count": 1, "structure_determination_methodology": "experimental", "structure_determination_methodology_priority": 10, "diffrn_resolution_high": {"provenance_source": "Depositor assigned", "value": 1.66}}, "rcsb_primary_citation": {"country": "UK", "id": "primary", "journal_abbrev": "Bioorg.Med.Chem.", "journal_id_astm": "BMECEP", "journal_id_csd": "1200", "journal_id_issn": "0968-0896", "journal_volume": "20", "page_first": "5313", "pdbx_database_id_doi": "10.1016/J.BMCL.2010.06.126", "pdbx_database_id_pub_med": 20650636, "rcsb_authors": ["Anselm, L.", "Banner, D.W.", "Benz, J.", "Groebke Zbinden, K.", "Himber, J.", "Hilpert, H.", "Huber, W.", "Kuhn, B.", "Mary, J.L.", "Otteneder, M.B.", "Panday, N.", "Ricklin, F.", "Stahl, M.", "Thomi, S.", "Haap, W."], "rcsb_journal_abbrev": "Bioorg Med Chem", "title": "Discovery of a Factor Xa Inhibitor (3R,4R)-1-(2,2-Difluoro-Ethyl)-Pyrrolidine-3,4-Dicarboxylic Acid 3-[(5-Chloro-Pyridin-2-Yl)-Amide] 4-{[2-Fluoro-4-(2-Oxo-2H-Pyridin-1-Yl)-Phenyl]-Amide} as a Clinical Candidate.", "year": 2010}, "refine": [{"aniso_b11": -0.07, "aniso_b12": 0.0, "aniso_b13": 0.0, "aniso_b22": -0.07, "aniso_b23": 0.0, "aniso_b33": 0.14, "correlation_coeff_fo_to_fc": 0.963, "correlation_coeff_fo_to_fc_free": 0.944, "ls_rfactor_rfree": 0.23208, "ls_rfactor_rwork": 0.18838, "ls_rfactor_obs": 0.19057, "ls_dres_high": 1.7, "ls_dres_low": 74.94, "ls_number_reflns_rfree": 1356, "ls_number_reflns_obs": 25183, "ls_percent_reflns_rfree": 5.1, "ls_percent_reflns_obs": 82.48, "overall_sub": 2.352, "overall_suml": 0.078, "pdbx_rfree_selection_details": "RANDOM", "pdbx_diffrn_id": ["1"], "pdbx_ls_cross_valid_method": "THROUGHOUT", "pdbx_method_to_determine_struct": "MOLECULAR REPLACEMENT", "pdbx_overall_esur": 0.136, "pdbx_overall_esurfree": 0.132, "pdbx_refine_id": "X-RAY DIFFRACTION", "pdbx_solvent_ion_probe_radii": 0.8, "pdbx_solvent_shrinkage_radii": 0.8, "pdbx_solvent_vdw_probe_radii": 1.2, "pdbx_starting_model": "IN HOUSE", "pdbx_stereochemistry_target_values": "MAXIMUM LIKELIHOOD", "solvent_model_details": "BABINET MODEL WITH MASK", "biso_mean": 37.951}], "refine_hist": [{"cycle_id": "LAST", "d_res_high": 1.7, "d_res_low": 74.94, "number_atoms_solvent": 175, "number_atoms_total": 2384, "pdbx_number_atoms_ligand": 39, "pdbx_number_atoms_nucleic_acid": 0, "pdbx_number_atoms_protein": 2170, "pdbx_refine_id": "X-RAY DIFFRACTION"}], "refine_ls_restr": [{"dev_ideal": 0.011, "dev_ideal_target": 0.022, "number": 2260, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_bond_refined_d"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_bond_other_d"}, {"dev_ideal": 1.288, "dev_ideal_target": 1.969, "number": 3057, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_angle_refined_deg"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_angle_other_deg"}, {"dev_ideal": 5.787, "dev_ideal_target": 5.0, "number": 275, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_dihedral_angle_1_deg"}, {"dev_ideal": 36.003, "dev_ideal_target": 23.922, "number": 102, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_dihedral_angle_2_deg"}, {"dev_ideal": 12.754, "dev_ideal_target": 15.0, "number": 384, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_dihedral_angle_3_deg"}, {"dev_ideal": 15.107, "dev_ideal_target": 15.0, "number": 15, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_dihedral_angle_4_deg"}, {"dev_ideal": 0.087, "dev_ideal_target": 0.2, "number": 325, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_chiral_restr"}, {"dev_ideal": 0.006, "dev_ideal_target": 0.021, "number": 1722, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_gen_planes_refined"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_gen_planes_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_nbd_refined"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_nbd_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_nbtor_refined"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_nbtor_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_xyhbond_nbd_refined"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_xyhbond_nbd_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_metal_ion_refined"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_metal_ion_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_symmetry_vdw_refined"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_symmetry_vdw_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_symmetry_hbond_refined"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_symmetry_hbond_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_symmetry_metal_ion_refined"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_symmetry_metal_ion_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_mcbond_it"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_mcbond_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_mcangle_it"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_mcangle_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_scbond_it"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_scbond_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_scangle_it"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_scangle_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_long_range_B_refined"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_long_range_B_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_rigid_bond_restr"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_sphericity_free"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_sphericity_bonded"}], "reflns": [{"d_resolution_high": 1.66, "d_resolution_low": 20.0, "number_obs": 28575, "observed_criterion_sigma_i": -3.0, "pdbx_rmerge_iobs": 0.1, "pdbx_diffrn_id": ["1"], "pdbx_net_iover_sigma_i": 10.08, "pdbx_ordinal": 1, "pdbx_redundancy": 9.21, "percent_possible_obs": 83.0}], "reflns_shell": [{"rmerge_iobs": 0.89, "d_res_high": 1.66, "d_res_low": 1.76, "mean_iover_sig_iobs": 2.56, "pdbx_diffrn_id": ["1"], "pdbx_ordinal": 1, "pdbx_redundancy": 8.4, "percent_possible_all": 95.5}], "software": [{"classification": "refinement", "name": "REFMAC", "pdbx_ordinal": 1, "version": "5.6.0062"}, {"classification": "data reduction", "name": "XDS", "pdbx_ordinal": 2}, {"classification": "data scaling", "name": "XDS", "pdbx_ordinal": 3}, {"classification": "phasing", "name": "MOLREP", "pdbx_ordinal": 4}], "struct": {"pdbx_descriptor": "ACTIVATED FACTOR XA HEAVY CHAIN (E.C.3.4.21.6), FACTOR X LIGHT CHAIN (E.C.3.4.21.6)", "title": "Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor"}, "struct_keywords": {"pdbx_keywords": "BLOOD CLOTTING", "text": "BLOOD CLOTTING, COAGULATION, COAGULATION FACTOR, HYDROLASE, HYDROXYLATION, SERINE PROTEASE, ZYMOGEN"}, "symmetry": {"int_tables_number": 96, "space_group_name_hm": "P 43 21 2"}, "rcsb_id": "2XC5", "rcsb_binding_affinity": [{"comp_id": "OYJ", "type": "Ki", "value": 62.0, "unit": "nM", "reference_sequence_identity": 100, "provenance_code": "BindingDB", "link": "http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=2XC5"}, {"comp_id": "OYJ", "type": "Ki", "value": 62.0, "unit": "nM", "provenance_code": "Binding MOAD", "link": "http://www.bindingmoad.org/pdbrecords/index/2xc5"}]}